This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a limitation of several immunoassays for measuring myelin basic protein? ... (Read 25 times)

809779

  • Hero Member
  • *****
  • Posts: 579
Which of the following is a limitation of several immunoassays for measuring myelin basic protein?
 
  A) Myelin basic protein is fragmented in vivo by proteinases and can cause a problem with antibody specificity.
  B) The assays may yield false-negative results in a patient with abnormally low CSF albumin.
  C) The assays may yield false-positive results in patients with abnormally high CSF IgG.
  D) Oligoclonal proteins may interfere with the assays.

Question 2

A 35-year-old male was admitted to the ED with flu-like symptoms. Among the many diagnostic tests performed, his CSF lactate was 20 mg/dL. Which of the following is a likely candidate for this result?
 
  A) The patient has diabetes.
  B) The patient may have viral meningitis.
  C) The patient has suffered a subarachnoid hemorrhage.
  D) The patient has hepatitis.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

diana chang

  • Sr. Member
  • ****
  • Posts: 288
Answer to Question 1

A

Answer to Question 2

B




809779

  • Member
  • Posts: 579
Reply 2 on: Jun 25, 2018
Wow, this really help


komodo7

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

For a complete list of videos, visit our video library